The Future of Healthcare and Life Sciences Research Conference 2025
The Future of Life Sciences event brought together leaders from across the NHS, government, academia, and industry to tackle one of the UK’s greatest opportunities—and challenges: unlocking the full potential…
What does the new integrated rules-based med-tech pathway mean?
NHS England and NICE have published a consultation document which sets out proposals to move towards a more rules-based, integrated, and predictable pathway for the evaluation, funding, and commissioning of…
What does the General Election mean for UK Health and Life sciences
Prime Minister Rishi Sunak wrong-footed political commentators and analysts yesterday by calling a General Election on the 4th of July. The decision looks to have been driven by better economic…
Is the NHS finally developing a clear evaluation and reimbursement pathway for digital health technologies?
Today the National Institute for Health and Care Research (NIHR) in collaboration with the Office for Life Sciences (OLS) and the National Institute for Health and Care Excellence (NICE), opened…
Harnessing primary care data for clinical research and trial recruitment – supported by EMIS
The UK’s health and care system produces a vast amount of data that can support research and deliver improvements in the quality of care patients receive. Primary care data are…
Transformation of the lung cancer pathway in the UK: an opportunity for innovation
In November, Newmarket Strategy hosted a roundtable discussion on the Transformation of the Lung Cancer Pathway in the NHS. This event brought together leading academics, clinicians, and industry partners, providing…
The Government’s £650m ‘Life Sci for Growth’ package
Today, 26 May 2023, UK Chancellor Jeremy Hunt MP brought forward a huge package of life sciences announcements, revealing a £650m war chest to fire up the Life Sciences sector. The…
The Innovative Medicines Fund: Regressive Measures or A Worthy Successor?
A new Innovative Medicines Fund (IMF), the NHS England consultation on which closed last Friday, has the potential to make a meaningful impact on patient access to innovative, new medicines in England…
Introducing Newmarket Strategy – a new consultancy specialising in healthcare innovation
Today sees the launch of Newmarket Strategy, a strategic and technical advisory business specialising in healthcare and life sciences. This new venture brings together three existing companies whose leaders have…